Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma.
Authors: Sudha P; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana., Johnson TS; Department of Biostatistics and Health Data Sciences, School of Medicine, Indiana University, Indianapolis, Indiana., Hamidi H; Genentech Inc., South San Francisco, California., Yang K; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana., Liu E; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana., Smith B; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana., Chopra V; Genentech Inc., South San Francisco, California., Nixon M; Genentech Inc., South San Francisco, California., Zafar F; Genentech Inc., South San Francisco, California., Farag SS; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana., Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Landgren O; Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Lee K; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana., Suvannasankha A; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana., Czader M; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana., Abonour R; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana., Abu Zaid M; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana., Walker BA; Division of Hematology and Oncology, Melvin and Bren Simon Comprehensive Cancer Center, School of Medicine, Indiana University, Indianapolis, Indiana.; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, Indiana.
Source: Cancer immunology research [Cancer Immunol Res] 2025 Jul 02; Vol. 13 (7), pp. 1070-1079.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2326-6074
DOI:10.1158/2326-6066.CIR-25-0019